Korbel Gregory Alan
SEC CIK 1789032 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| APRE | Aprea Therapeutics, Inc. | SVP, Chief Business Off, Dir | 45.8K | — | $544.7K | 15 | 2021-08-25 | 2022-07-28 |
Most active insiders at APRE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Duey Marc | Dir | $25.1K | — |
| 2 | Gilad Oren | Pres, CEO, Dir | $25.0K | — |
| 3 | Hamill John P. | CFO, SrVP, Prin Fin, Acct Ofcr | $10.9K | — |
| 4 | Pamukcu Rifat | Dir | — | — |
| 5 | Gruia Gabriela | Dir | — | — |
| 6 | Seizinger Bernd R. | Dir | — | — |
| 7 | Grissinger Michael | Dir | — | — |
| 8 | Peters Richard | Dir | — | — |
| 9 | BIZZARI JEAN-PIERRE | Dir | — | — |
| 10 | HENNEMAN JOHN B III | Dir | — | — |
Korbel Gregory Alan made no open-market trades at APRE in the last 12 months.
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-08-01 | 2022-07-28 | APRE | Aprea Therapeutics, Inc. | Korbel Gregory Alan | SVP, COO | A - Grant | $0.00 | +24.3K | 45.8K | +113% | $0 |
| 2022-06-07 | 2022-06-03 | APRE | Aprea Therapeutics, Inc. | Korbel Gregory Alan | SVP, COO, Dir | F - Tax | $0.81 | -8,390 | 21.5K | -28% | -$6,796 | |
| D | 2022-03-14 | 2022-03-10 | APRE | Aprea Therapeutics, Inc. | Korbel Gregory Alan | SVP, Chief Business Off, Dir | F - Tax | $1.82 | -1,989 | 29.9K | -6% | -$3,620 |
| D | 2022-03-14 | 2022-03-10 | APRE | Aprea Therapeutics, Inc. | Korbel Gregory Alan | SVP, Chief Business Off, Dir | A - Grant | $0.00 | +16.0K | 31.8K | +101% | $0 |
| 2022-03-01 | 2022-02-25 | APRE | Aprea Therapeutics, Inc. | Korbel Gregory Alan | SVP, Chief Business Off | F - Tax | $1.74 | -1,326 | 15.8K | -8% | -$2,307 | |
| D | 2021-12-03 | 2021-12-01 | APRE | Aprea Therapeutics, Inc. | Korbel Gregory Alan | SVP, Chief Business Off | M - OptEx | $0.92 | +27.5K | 44.7K | +160% | +$25.3K |
| D | 2021-12-03 | 2021-12-01 | APRE | Aprea Therapeutics, Inc. | Korbel Gregory Alan | SVP, Chief Business Off | S - Sale+OE | $3.96 | -27.5K | 17.2K | -62% | -$108.9K |
| D | 2021-11-03 | 2021-11-01 | APRE | Aprea Therapeutics, Inc. | Korbel Gregory Alan | SVP, Chief Business Off | S - Sale+OE | $5.00 | -27.5K | 17.2K | -62% | -$137.5K |
| D | 2021-11-03 | 2021-11-01 | APRE | Aprea Therapeutics, Inc. | Korbel Gregory Alan | SVP, Chief Business Off | M - OptEx | $0.92 | +27.5K | 44.7K | +160% | +$25.3K |
| D | 2021-10-05 | 2021-10-01 | APRE | Aprea Therapeutics, Inc. | Korbel Gregory Alan | SVP, Chief Business Off | S - Sale+OE | $4.89 | -27.5K | 17.2K | -62% | -$134.5K |
| D | 2021-10-05 | 2021-10-01 | APRE | Aprea Therapeutics, Inc. | Korbel Gregory Alan | SVP, Chief Business Off | M - OptEx | $0.92 | +27.5K | 44.7K | +160% | +$25.3K |
| DM | 2021-09-22 | 2021-09-20 | APRE | Aprea Therapeutics, Inc. | Korbel Gregory Alan | SVP, Chief Business Off | S - Sale+OE | $4.97 | -33.0K | 17.2K | -66% | -$163.9K |
| D | 2021-09-22 | 2021-09-20 | APRE | Aprea Therapeutics, Inc. | Korbel Gregory Alan | SVP, Chief Business Off | M - OptEx | $0.92 | +27.5K | 44.7K | +160% | +$25.3K |
| 2021-09-14 | 2021-09-10 | APRE | Aprea Therapeutics, Inc. | Korbel Gregory Alan | Chief Business Off | F - Tax | $4.59 | -1,724 | 22.6K | -7% | -$7,913 | |
| 2021-08-27 | 2021-08-25 | APRE | Aprea Therapeutics, Inc. | Korbel Gregory Alan | Chief Business Off | F - Tax | $3.98 | -1,149 | 24.4K | -5% | -$4,573 |
Purchase Sale Sale after option exercise All abbreviations